Matches in Wikidata for { <http://www.wikidata.org/entity/Q37310162> ?p ?o ?g. }
- Q37310162 description "article científic" @default.
- Q37310162 description "article scientifique" @default.
- Q37310162 description "articolo scientifico" @default.
- Q37310162 description "artigo científico" @default.
- Q37310162 description "artículu científicu espublizáu en 2009" @default.
- Q37310162 description "bilimsel makale" @default.
- Q37310162 description "scientific article published on 18 August 2009" @default.
- Q37310162 description "vedecký článok" @default.
- Q37310162 description "vetenskaplig artikel" @default.
- Q37310162 description "videnskabelig artikel" @default.
- Q37310162 description "vědecký článek" @default.
- Q37310162 description "wetenschappelijk artikel" @default.
- Q37310162 description "wissenschaftlicher Artikel" @default.
- Q37310162 description "наукова стаття, опублікована в серпні 2009" @default.
- Q37310162 description "научни чланак" @default.
- Q37310162 description "مقالة علمية نشرت في 18 أغسطس 2009" @default.
- Q37310162 name "Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study" @default.
- Q37310162 name "Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study" @default.
- Q37310162 name "Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study." @default.
- Q37310162 type Item @default.
- Q37310162 label "Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study" @default.
- Q37310162 label "Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study" @default.
- Q37310162 label "Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study." @default.
- Q37310162 prefLabel "Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study" @default.
- Q37310162 prefLabel "Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study" @default.
- Q37310162 prefLabel "Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study." @default.
- Q37310162 P1433 Q37310162-C5C547FB-3FA0-401B-997A-BBF25A8E375A @default.
- Q37310162 P1476 Q37310162-17040D02-3E42-488F-9C87-D6DD0F575DD8 @default.
- Q37310162 P2093 Q37310162-07E490EC-81A7-4415-A24B-551CC97BD740 @default.
- Q37310162 P2093 Q37310162-6E83CC0C-BCC7-4558-8394-C13F9C320BED @default.
- Q37310162 P2093 Q37310162-A2A13C0D-85B0-4031-99B3-580E8719D74D @default.
- Q37310162 P2093 Q37310162-A7B0EA6E-D565-43B0-AA05-30C152B862BF @default.
- Q37310162 P2093 Q37310162-E3F9EA8D-87FD-4361-9C1F-8DDF1BA23614 @default.
- Q37310162 P2860 Q37310162-0B43E968-359A-48F0-B6C4-9F1015CC26A2 @default.
- Q37310162 P2860 Q37310162-1BB827EE-D7A8-4DCD-90D7-CB7BB8F3DB44 @default.
- Q37310162 P2860 Q37310162-262B6AEC-1B40-4AED-969C-604DF6764062 @default.
- Q37310162 P2860 Q37310162-2B2F85B7-B205-48A1-888B-6C171C0BE503 @default.
- Q37310162 P2860 Q37310162-3AF75B1A-8A5E-41E6-B8DF-53F5988ED3D0 @default.
- Q37310162 P2860 Q37310162-44243E2F-DC4F-4C50-8293-FA66ADBC7CE8 @default.
- Q37310162 P2860 Q37310162-48F343CA-B240-4ABB-84E5-CDCEC8B816E0 @default.
- Q37310162 P2860 Q37310162-4E2523D1-435D-48BA-A378-5A225E3B4815 @default.
- Q37310162 P2860 Q37310162-5189C38A-2109-4707-90FB-B2B810F89644 @default.
- Q37310162 P2860 Q37310162-55FC0C31-425D-49FD-9485-6804BCE994D1 @default.
- Q37310162 P2860 Q37310162-5696541E-44E2-422F-ACCA-367E40A4C723 @default.
- Q37310162 P2860 Q37310162-610F7EA1-A81B-47EB-87AF-A595F430F009 @default.
- Q37310162 P2860 Q37310162-7738C652-07BD-4123-BB1C-D6D9ECBFCFA2 @default.
- Q37310162 P2860 Q37310162-784DF60A-27B2-40CC-969E-91DD3F1CC134 @default.
- Q37310162 P2860 Q37310162-78D9D86C-2BEB-4676-A36C-BE0A42A33497 @default.
- Q37310162 P2860 Q37310162-805EF9AC-5AAC-4CA2-91A4-F080D2168121 @default.
- Q37310162 P2860 Q37310162-84CEECD8-2A33-4676-BCD1-A8DB2EC691FE @default.
- Q37310162 P2860 Q37310162-864FA341-C5F2-4DB9-8804-D20AA271CEA2 @default.
- Q37310162 P2860 Q37310162-8891D778-E049-47EA-9372-A00FC2EF82A0 @default.
- Q37310162 P2860 Q37310162-89D3878A-76D7-413B-9CA4-9D32137C6903 @default.
- Q37310162 P2860 Q37310162-929154D0-F475-48C0-AB73-D44E1E4AD09B @default.
- Q37310162 P2860 Q37310162-9B92C719-7A4C-4587-93B4-87D661FA27BD @default.
- Q37310162 P2860 Q37310162-9E18FF13-F3E5-4286-B258-80DECFCD08D8 @default.
- Q37310162 P2860 Q37310162-AC7215D7-AE44-47B5-88C4-FFDEB0D2EAC3 @default.
- Q37310162 P2860 Q37310162-AECD700D-0911-49FF-BA1D-E43B770B5B7F @default.
- Q37310162 P2860 Q37310162-C5E8E9F3-7AFD-443E-8311-7579ED8814FA @default.
- Q37310162 P2860 Q37310162-C8BC1C54-A75E-4F3E-9C59-D47139797FB6 @default.
- Q37310162 P2860 Q37310162-D0DF37C1-2EB1-40ED-A95A-9DCE5F8D5651 @default.
- Q37310162 P2860 Q37310162-D2B57F69-C3CC-4244-8024-294DDE61A5DB @default.
- Q37310162 P2860 Q37310162-D8679B0F-00D7-4232-8B2A-6B175B131E3E @default.
- Q37310162 P2860 Q37310162-E08BC6C8-FF14-4D7D-A5BF-F50997D07C57 @default.
- Q37310162 P2860 Q37310162-E2DB3961-8B98-4546-9297-FA9054E4F2E3 @default.
- Q37310162 P2860 Q37310162-ECCEE1D1-1004-4D38-9046-6C6D4AED961C @default.
- Q37310162 P2860 Q37310162-FB90628E-15C4-462D-BDDF-D6D0193185A3 @default.
- Q37310162 P2860 Q37310162-FCA5E92F-B2F2-4F88-9DE3-7993510632E9 @default.
- Q37310162 P304 Q37310162-E20C4031-53FD-4802-8761-362C6C31F83A @default.
- Q37310162 P31 Q37310162-5E3AEB92-8C6F-465B-B3A1-DE60FC649D70 @default.
- Q37310162 P356 Q37310162-FC9720E4-88BE-4C30-BD2C-B431E69337B5 @default.
- Q37310162 P407 Q37310162-1F578BCD-FF20-440A-BC18-DEE770A6F5D8 @default.
- Q37310162 P478 Q37310162-73D93095-DFEC-4849-9011-A46E5B46E0E2 @default.
- Q37310162 P50 Q37310162-F8546541-4FC7-48A9-BE66-FD409C895332 @default.
- Q37310162 P577 Q37310162-BBEFB089-1837-4FAC-8038-AC046ED202E3 @default.
- Q37310162 P5875 Q37310162-07E2E10D-E10D-4732-8CCC-1F4FB44B84B4 @default.
- Q37310162 P698 Q37310162-0C466891-0FE4-49DB-B9AC-46CB858C4A00 @default.
- Q37310162 P921 Q37310162-06A41F4D-EDCF-4916-A9ED-EA6D7B645200 @default.
- Q37310162 P921 Q37310162-2D34AC67-B4B2-4C30-B201-E3FD9E7FFD0E @default.
- Q37310162 P932 Q37310162-A389548D-C31B-4859-8B65-AD4DFC46AD0D @default.
- Q37310162 P356 BMJ.B2942 @default.
- Q37310162 P698 19690342 @default.
- Q37310162 P1433 Q546003 @default.
- Q37310162 P1476 "Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study" @default.
- Q37310162 P2093 "David N Juurlink" @default.
- Q37310162 P2093 "Janet E Hux" @default.
- Q37310162 P2093 "Lorraine L Lipscombe" @default.
- Q37310162 P2093 "Muhammad M Mamdani" @default.
- Q37310162 P2093 "Tara Gomes" @default.
- Q37310162 P2860 Q22250883 @default.
- Q37310162 P2860 Q27860575 @default.
- Q37310162 P2860 Q28299842 @default.
- Q37310162 P2860 Q29619886 @default.
- Q37310162 P2860 Q30677305 @default.
- Q37310162 P2860 Q30713396 @default.
- Q37310162 P2860 Q30980766 @default.
- Q37310162 P2860 Q33878917 @default.
- Q37310162 P2860 Q33937132 @default.
- Q37310162 P2860 Q34599640 @default.
- Q37310162 P2860 Q34634794 @default.